Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-14

Clinical Trial Update: D-Cycloserine Enhancement of Exposure in Social Phobia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial tested whether D-Cycloserine can enhance exposure therapy for Social Anxiety Disorder; the study has completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-cycloserine (D-cycloserine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Social Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-05-14